This year proved a blockbuster for stocks, from cryptocurrency to the Magnificent Seven and manufacturers of weight loss drugs. Highlights included five of the stealthiest performers with major returns who each capitalized on distinct global trends. In count, there was Abercrombie and Fitch, soaring an impressive 290%, ciphering their return to the enthusiasm of modern millennials. Seemingly unrelated, a season-long drought in Europe unexpectedly skyrocketed prices for olives and olive oil. Cocoa materials faced similar headwindswith price spikes reaching 45-year highs, fueled by cultivator- harming weather irregularity. Poor ETF performance in the cryptocurrency space in 2022 could not preclude quite a spectacular turnaround in solana signaling a 560% surge in multiple token purchase by now jailed CEO Sam Bankman-Fried from potent sister firm, Alameda. Lastly, uranium prices soured to life heights exceeding $80 for the first time in 15 years attrading growth of 125%, backed by soaring interest in nuclear power and the renewables backdrop.
